Ptc Therapeutics (PTCT) Depreciation and Depletion (2012 - 2020)

Ptc Therapeutics' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at -$24.5 million for Q4 2020.

• In Q4 2020, Depreciation and Depletion fell 34.53% year-over-year to -$24.5 million; the TTM figure through Dec 2020 stood at $6.6 million (up 40.43% YoY), while the FY2024 annual figure was $14.9 million, up 7.19% from the prior year.
• Depreciation and Depletion was -$24.5 million for Q4 2020 at Ptc Therapeutics, down from $11.6 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $11.6 million in Q3 2020 to a low of -$24.5 million in Q4 2020.
• Historically, Depreciation and Depletion has averaged $975000.0 across 5 years, with a median of $3.4 million in 2016.
• Biggest YoY gain for Depreciation and Depletion was 1166.3% in 2017; the steepest drop was 1247.39% in 2017.
• A 5-year view of Depreciation and Depletion shows it stood at $823000.0 in 2016, then slumped by 1247.39% to -$9.4 million in 2017, then slumped by 77.02% to -$16.7 million in 2018, then fell by 8.9% to -$18.2 million in 2019, then tumbled by 34.53% to -$24.5 million in 2020.
• The last three Depreciation and Depletion figures came in at -$24.5 million (Q4 2020), $11.6 million (Q3 2020), and $10.2 million (Q2 2020), per Business Quant data.